GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,648.60p
   
  • Change Today:
      0.20p
  • 52 Week High: 1,846.00
  • 52 Week Low: 1,374.60
  • Currency: UK Pounds
  • Shares Issued: 5,017m
  • Volume: 8,286,250
  • Market Cap: £82,712m
  • RiskGrade: 170

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.9% 4.8%
Div Cover 1.5 1.5
Op Mrgn 20.6% 23.9%
ROCE 59.5%  
Latest F'cast
P/E 13.3 14.3
PEG 3.5 n/a
Pr/Revenue 2.5 2.4
Pr/Book 4.5  
Latest F'cast
Revenue 9.5% 4.7%
PBT 29.6% 35.9%
EPS 3.8% -6.2%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 35,325.96 8,453.11 116.17p 14.2 n/a -6% 80.00p 4.8%
31-Dec-21 36,389.80 8,818.87 118.30p 13.9 7.6 +2% 80.07p 4.8%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Block listing Interim Review 26-May-2020 11:53 RNS
Holding(s) in Company 19-May-2020 17:51 RNS
ViiV PrEP jab shows high efficacy over daily pill 18-May-2020 07:09 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
12-May-20 Transfer From Emma Walmsley 0.000p 7 £0.00
12-May-20 Buy Emma Walmsley 1,692.88p 7 £118.50
29-Apr-20 Buy Urs Rohner 1,693.00p 609 £10,310.37

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,648.60p
Change Today 0.20p
% Change 0.01 %
52 Week High 1,846.00
52 Week Low 1,374.60
Volume 8,286,250
Shares Issued 5,017m
Market Cap £82,712m
RiskGrade 170

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.56% below the market average59.56% below the market average59.56% below the market average59.56% below the market average59.56% below the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Price Trend
64.41% above the market average64.41% above the market average64.41% above the market average64.41% above the market average64.41% above the market average
10.71% below the sector average10.71% below the sector average10.71% below the sector average10.71% below the sector average10.71% below the sector average
Income
57.16% above the market average57.16% above the market average57.16% above the market average57.16% above the market average57.16% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
30.54% above the market average30.54% above the market average30.54% above the market average30.54% above the market average30.54% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 11
Sell 0
Strong Sell 3
Total 22
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-20 20-Feb-20
Paid 09-Jul-20 09-Apr-20
Amount 19.00p 23.00p

Trades for 27-May-2020

Time Volume / Share Price
16:50 37 @ 1,637.40p
16:50 41 @ 1,637.40p
16:50 5 @ 1,637.40p
16:50 1,783 @ 1,637.40p
16:35 3,041,803 @ 1,648.60p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page